Hosted by the American Health Law Association
The life sciences industry is in a state of evolution and breakthroughs, but also constant challenges.
So how are legal teams protecting innovation, managing risk, and driving value without letting costs spiral?
To find out, in February of 2025, UnitedLex commissioned a third-party blind survey of 100+ senior legal and operations leaders—including CLOs, GCs, and legal directors. The results reveal where legal teams are investing their time and budget, what’s interrupting their sleep, and what they’re doing to optimize performance in the year ahead.
Join us and the American Health Law Association (AHLA) for this free webinar, From Lab to Legal: How Life Sciences Teams Are Managing Risk, Protecting IP, and Driving Value. Experts from Bristol Myers Squibb, Kohler Health Law and UnitedLex will unpack the survey findings and share how leading teams are managing the challenges shaping legal ops, IP strategy, and litigation management across the life sciences industry.
Register to save your spot and hear panelists share insights on topics and findings such as:
- 59% of IP teams now have defensive strategies against NPEs
- 52% of legal departments say mass torts and MDLs have the greatest impact on their legal strategy
- 61% of respondents plan to streamline contract management in 2025
- And 75% of legal departments already use or plan to use AI in the next year